Newsroom Stories

Senior Kai Radford started serving St. Louis’ children when she, herself, was a child — reading at story times, helping at camps, supporting victims of violence. A decade later, she is poised to continue that work as a foster care case manager, building strong families and advocating for some of the 4,500 local children in the foster care system. 

The new St. Louis Confluence Award recognizes and elevates the strength and impact of the work led by community-minded researchers, their partners and university collaborators. The inaugural recipient is the Brown School’s Matthew Kreuter.

Stress causes the levels of Alzheimer’s proteins to rise in females’ brains but not males’ brains, according to a new study in mice by researchers at the School of Medicine. This difference may contribute to women’s greater risk of developing Alzheimer’s disease.

Since 1973, WILD has been an annual tradition at Washington University in St. Louis, bringing together students for a night of unforgettable performances. To celebrate 2023’s golden WILD, the 50th anniversary of the event’s inception, look back at the history and impact of WILD over the years.

Workday Student, the system that will replace the majority of WashU’s student information systems, including WebSTAC and WUCRSL, is on track to go live over the course of the 2024-25 academic year.

Pamela K. Woodard, MD, a national leader in cardiothoracic imaging, has been named head of the Department of Radiology, director of the Mallinckrodt Institute of Radiology and the Elizabeth E. Mallinckrodt Professor of Radiology at the School of Medicine.

The pre-nursing program at University College gives School of Medicine employees and other working adults the academic foundation to enter a bachelor’s of nursing program. The program is flexible, feasible and for most university employees, free. 

The seventh annual Wealth & Asset Management Research Conference — a collaboration between Olin Business School, Edward Jones, CFA Society–St. Louis and Dimensional — will take place May 3 and 4. 

A new drug has been approved by the Food and Drug Administration (FDA) for a rare, inherited form of amyotrophic lateral sclerosis (ALS). The drug — based in part on research conducted at the School of Medicine — slows the progression of the deadly, paralyzing disease.

A new study led by the School of Medicine suggests that circadian rhythm — the natural cycle of physical and other changes our bodies go through in a 24-hour period — may affect the body’s response to the COVID-19 vaccine. The research suggests that vaccines given around the middle of the day may prevent more infections.